The industry analysis specialist's new report, "Bladder Cancer - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global bladder cancer market. The report identifies the key trends shaping and driving the global bladder cancer market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global bladder cancer sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis team of industry experts.

Scope

Annualized global bladder cancer therapeutics market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.

Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.

Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include Anti-metabolites, DNA synthesis inhibitors, Photodynamic therapy, Plasmid/Gene mediated therapies, Growth factor inhibitors, Heat shock protein Inhibitors and Anti mitotic inhibitors,

Analysis of the current and future market competition in the global bladder cancer therapeutics market. Key market players covered are Spectrum Pharmaceuticals, Bioniche Life Sciences, Sanofi-Aventis and OncoGeneX Inc.

Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with bladder cancer.

For More Information Please Click:


Or Call Us: 919272852585
Visit Our Blog: